에 대한 최신 뉴스 MSCI (NYSE:MSCI) 주식

MSCI

MSCI has described its mission as enabling investors to build better portfolios for a better world. MSCI's largest and most profitable segment is its index segment, where it provides benchmarking to asset managers and asset owners. In addition, it boasts over $1.4 trillion in ETF assets linked to MSCI indexes. The MSCI analytics segment provides portfolio management and risk management analytics software to asset managers and asset owners. MSCI's all other segment was broken out into ESG and climate and private assets segments in 2021. In ESG and climate, MSCI provides ESG data to the investment industry. In private assets, MSCI provides real restate reporting, market data, benchmarking, and analytics to investors and real estate managers.

Large Cap

News

Price Target

Movers

New Oriental Education & Technology Group

MANH

지난주 최하 성과 주식: 이 10개의 대형주가 포트폴리오에 있나요? (4월 21일-27일)

MSCI Inc

MSCI ACWI UCITS ETF

MSCI ADLA ETF

MSCI ALL CHINA HLTH CARE UCITS ETF USD

MSCI CHI ESG LDRS UCITS ETF

MSCI CHINA A SHARE UCITS ETF

MSCI GB TEL US ACC ETF

MSCI KOREA INDEX UCITS (DR) 1C ETF

MSCI ORD

MSCI SDG 11 ETF

MSCI SDG 12 ETF

MSCI USA LCS ETF

MSCI USA SC ESG ETF

MSCI USA TRN INDEX SF A USD ETF

MSCI WD COM ESG ETF

MSCI WD ENG ESG ETF

MSCI WD IND ESG ETF

MSCI WD MAT ESG ETF

MSCI WLD SWP US AC ETF

MSCI WS CAP ETF

Evercore ISI Group analyst David Motemeden initiates coverage on MSCI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) with a Outperform rating and announces Price Target of $690.

Initiation

Analyst Ratings

Evercore ISI Group Initiates Coverage On MSCI with Outperform Rating, Announces Price Target of $690

MSCI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) has outperformed the market over the past 10 years by 17.43% on an annualized basis producing an average annual return of 28.87%. Currently, MSCI has a market capitalization of $45.82 billion. 
Buying $1000 In MSCI: If an investor had bought $1000 of MSCI stock 10 years ago, it would be worth $12,266.87 today based on a price of $582.93 for MSCI at the time of writing.
<h3>MSCI's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727809263_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$1000 Invested In MSCI 10 Years Ago Would Be Worth This Much Today

WIIM

ATAT

BIDU

BILI

BZUN

DADA

FUTU

MNSO

NTES

YUMC

ZLAB

Shares of US-listed Chinese companies are trading higher on continued strength amid stimulus efforts. September PMI data beat estimates but factory activity fell, which may raise stimulus hopes.

BABA

BEKE

HTHT

Citigourp Global Markets 2% Protected Notes Linked To The Djia

TCOM

XPEV

Shares of US-listed Chinese companies are trading higher possibly amid continued strength following a report suggesting China will issue up to $284 billion of sovereign debt as part of a stimulus.

Shares of Chinese stocks are trading higher following a report suggesting China will issue up to $284 billion of sovereign debt as part of a stimulus.

MSCI (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/msci#NYSE">MSCI</a>) shares moved up 6.7% in the past year compared with the broader Zacks Computer and Technology sector&#39;s return of 39.8% and the Zacks Business - Software Services sector&#39;s rise of 29.2%.
The underperformance is likely to have been caused by a tighter spending environment and longer sales cycles due to challenging macroeconomic conditions.
Increasing pricing pressure is also a major concern, primarily due to the growing availability of free indices from providers like Morningstar (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/morn#NASDAQ">MORN</a>).
As Morningstar continues to offer more accessible options, self-indexing and lower spending by asset managers on gathering data are other headwinds.
<div class="chart_embed">
<h3>MSCI Inc Price and Consensus</h3>
<img alt="MSCI Inc Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/20/1727099080.png" style="height:278px; width:620px" title="" />
MSCI Inc price-consensus-chart | MSCI Inc Quote
Despite these challenges, MSCI is benefiting from strong demand for custom and factor index modules, recurring revenue business models and the growing adoption of its ESG and Climate solutions in the investment process.
Hence, investors should ask this question &mdash; is now the right time to invest in MSCI&#39;s shares given the current market challenges and MSCI&#39;s performance?
</div>
<h3>Will MSCI&#39;s Strong Portfolio Drive Growth?</h3>
MSCI&#39;s expanding portfolio along with robust adoption of its Climate and ESG solutions, have been a major growth driver.
In July, the company announced a partnership with Moody&#39;s, marking a milestone in advancing ESG (Environmental, Social and Governance) transparency in financial markets.
MSCI announced a partnership with Moody&#39;s. The partnership will leverage MSCI&#39;s robust sustainability data and models, widely utilized by major asset managers worldwide, to bolster Moody&#39;s offerings across banking, insurance and corporate sectors.
Moody&#39;s will also integrate MSCI&#39;s industry-leading ESG ratings and content into its solutions, gradually replacing its own ESG data offerings. The agreement also entails MSCI gaining access to Moody&#39;s extensive Orbis database, paving the way for expanded private company ESG coverage and exploration into advanced solutions for the private credit market.
MSCI&#39;s partnership with Microsoft has further expanded its clientele and is considered a major positive for the company.
The partnership with Microsoft aims to enhance the global investment industry by leveraging Microsoft&#39;s cloud and AI technologies to modernize MSCI&#39;s products and drive ESG solutions.
In second-quarter 2024, MSCI achieved 10% organic revenue growth, driven by strong performance across various segments, including Analytics, ESG and Index Investments. The company witnessed growth in its ESG and Climate solutions, with organic run rate growth of 14%.
Acquisitions have also played a significant role in shaping the company&#39;s growth trajectory. In April, MSCI completed the acquisition of Foxberry, a London-based index provider, aimed at enhancing custom index production capabilities and providing simulation and back-testing capabilities for institutional investors.
<h3>MSCI&#39;s Earnings Estimates Show Upward Movement</h3>
MSCI&#39;s diverse portfolio and strategic acquisitions are contributing to its growth prospects continuously and driving top-line growth.
The Zacks Consensus Estimate for third-quarter 2024 revenues is currently pegged at $710.74 million, suggesting 13.64% growth year over year.
The consensus mark for earnings is currently pegged at $3.75 per share, unchanged in the past 30 days.
<h3>MSCI Shares are Overvalued</h3>
MSCI stock is not so cheap, as the Value Score of D suggests a stretched valuation at this moment.
The forward 12-month Price/Sales ratio for MSCI stands at 16.16X, higher than its Zacks Business - Software Services industry&#39;s 11.26X, reflecting a stretched valuation.
MSCI currently carries Zacks Rank #3 (Hold), suggesting that it may be wise to wait for a more favorable entry point in the stock.
<a href="https://www.zacks.com/stock/news/2340002/msci-shares-up-7-in-a-year-should-you-buy-hold-or-sell-the-stock?cid=CS-BENZ-FT-analyst_blog|rank_focused-2340002">To read this article on Zacks.com click here.</a>

Earnings

Macro Economic Events

Offerings

Economics

Markets

Tech

MORN

MSCI Shares Up 7% in a Year: Should You Buy, Hold or Sell the Stock?

Barclays analyst Manav Patnaik maintains MSCI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) with a Overweight and raises the price target from $650 to $700.

Barclays Maintains Overweight on MSCI, Raises Price Target to $700

Nasdaq Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDAQ#NASDAQ">NDAQ</a>) stock gained after B of A Securities analyst Craig Siegenthaler <a target="_blank" href="https://www.benzinga.com/quote/NDAQ/analyst-ratings" rel="noreferrer noopener">double-upgraded the stock</a> from Underperform to Buy and raised its price target from $53 to $90.
Siegenthaler applied a 25x multiple on his 2026 EPS to derive the price target. The multiple implies a slight discount to Nasdaq&#8217;s aspirational software and information services peer group but is a premium to its current valuation.
The analyst highlighted that the solutions segment now comprises 78% of revenue. Information services peers like S&amp;P Global Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPGI#NYSE">SPGI</a>), Moody&#8217;s Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCO#NYSE">MCO</a>), and MSCI Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) trade at 30x 2026E earnings and have a fair amount of overlap with Nasdaq&#8217;s Capital Access Platforms segment, the analyst said.
Similarly, its FinTech segment comprises 36% of group revenue, with management guiding toward 10%-14% growth over the medium term. Other financial vertical software companies MeridianLink, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLNK#NYSE">MLNK</a>), nCino, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNO#NASDAQ">NCNO</a>), and Jack Henry &amp; Associates, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JKHY#NASDAQ">JKHY</a>) with comparable growth profiles are trading around 30x-40x EPS, the analyst noted. Nasdaq, however, trades at just 21x consensus 2026 EPS, he added.
The analyst noted an upward rerating would stem from a pause in dealmaking, accelerated deleveraging, business streamlining, and an acceleration in revenue growth.
As per Siegenthaler, improving macroeconomic conditions in conjunction with long backlogs should make for an IPO rebound in 2025.
Specifically, equity market valuations have recovered to 2021 levels while volatility should normalize lower after the U.S. presidential election and Fed rate cuts, the analyst said.
At the same time, he added that private equity sponsors have a long pipeline of aging portfolio companies, and limited partners are demanding liquidity.
He said that a comeback in IPOs would directly benefit Nasdaq&#8217;s listings segment and have positive second-derivative impacts on its trading, corporate services, and financial data businesses.
Price Action: NDAQ stock traded higher by 2.22% at $72.97 at the last check on Wednesday.
Photo via Shutterstock

Reiteration

JKHY

MLNK

NCNO

NDAQ

SPGI

IPO Rebound And FinTech Growth Potential Is Helping Nasdaq: Analyst Double Upgrades Stock

AAPL

ASML

Third Point LLC Q2 2024 13F Shows New Positions Include 1.95M Apple Shares, 2.8M Amphenol Shares, 2.1M KB Home Shares, 1.37M Live Nation Shares, 275K Micron Shares, 240K Roper Technologies Shares, 150K MSCI Shares, 150K Dynatrace Shares, 80K ASML Shares, 650K CRH Shares, And 625K Hess Shares

Wells Fargo analyst Jason Haas initiates coverage on MSCI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) with a Equal-Weight rating and announces Price Target of $570.

Wells Fargo Initiates Coverage On MSCI with Equal-Weight Rating, Announces Price Target of $570

On CNBC's &#8220;Mad Money Lightning Round,&#8221; Jim Cramer said he wants to own the stock of MSCI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>).
On July 23, MSCI posted better-than-expected second-quarter financial results. MSCI reported fiscal 2024 second-quarter revenue growth of 14.0% year-on-year to $707.95 million, beating the analyst consensus e<a href="https://www.benzinga.com/news/earnings/24/07/39912184/msci-q2-earnings-impress-investors-ceo-emphasizes-on-robust-client-base-and-execution">stimate of $696.37 million</a>.
Cramer said he likes the business of New Fortress Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFE#NASDAQ">NFE</a>), but something's going wrong there. &#8220;I can't figure out how to turn the stock around,&#8221; he added.
On Aug. 5, Barclays analyst Theresa Chen maintained New Fortress Energy with an Equal-Weight and lowered the price target from $27 to $19.
The Mad Money host recommended holding on to RPM International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPM#NYSE">RPM</a>). &#8220;That is one great company, it's an under the radar one, and I want you to own it,&#8221; he added.
On July 25, RPM International reported better-than-expected fourth-quarter earnings.
&#8220;I heavily suggest that you buy much more DuPont (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>),&#8221; Cramer said.
On July 31, DuPont De Nemours reported better-than-expected second-quarter adjusted EPS and sales. Sales rose 2% Y/Y to $3.171 billion, beating the consensus of $3.049 billion. Organic sales remained flat Y/Y, with a 2% increase in volume offset by a 2% decrease in price.
Cramer recommended buying Palo Alto Networks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) and added that it is &#8220;terrific.&#8221;
Palo Alto will release the financial results for its fiscal fourth quarter and fiscal year 2024, after the closing bell on Monday, Aug. 19.
Price Action:
<ul>
<li>MSCI shares gained 1.7% to settle at $526.11 on Tuesday.</li>
<li>New Fortress Energy shares rose 1.6% to close at $16.40.</li>
<li>RPM shares gained 0.3% to close at $115.01.</li>
<li>DuPont shares gained 0.3% to settle at 78.05 on Tuesday.</li>
<li>Palo Alto shares rose 2.6% to close at $301.93 on Tuesday.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40194186/top-4-materials-stocks-which-could-rescue-your-portfolio-this-month">Top 4 Materials Stocks Which Could Rescue Your Portfolio This Month</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Media

PANW

Jim Cramer Calls This Tech Stock 'Terrific' And Says 'I Heavily Suggest That You Buy Much More' Of DuPont

NFLX

NVDA

Morgan Stanley Wealth Management Increases Portfolio Weights In Eli Lilly, Northrop Grumman Corp, Nvidia, MSCI; Decreases Portfolio Weights In JP Morgan Chase & Co, Palo Alto Networks, Netflix, NextEra Energy

Argus Research analyst John Eade maintains MSCI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) with a Buy and raises the price target from $520 to $600.

Argus Research Maintains Buy on MSCI, Raises Price Target to $600

Barclays analyst Manav Patnaik maintains MSCI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) with a Overweight and raises the price target from $600 to $650.

Barclays Maintains Overweight on MSCI, Raises Price Target to $650

RBC Capital analyst Ashish Sabadra reiterates MSCI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) with a Outperform and maintains $638 price target.

RBC Capital Reiterates Outperform on MSCI, Maintains $638 Price Target

Goldman Sachs analyst George Tong maintains MSCI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) with a Neutral and raises the price target from $526 to $590.

Goldman Sachs Maintains Neutral on MSCI, Raises Price Target to $590

Morgan Stanley analyst Toni Kaplan maintains MSCI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) with a Overweight and raises the price target from $615 to $640.

Morgan Stanley Maintains Overweight on MSCI, Raises Price Target to $640

On Tuesday, Wall Street saw a mixed session, with small-cap stocks outperforming large caps as investors anticipated key earnings reports from Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) and Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), set to be <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39910693/tesla-analyst-asks-do-earnings-matter-ahead-of-q2-report-robotaxis-china-ev-guidanc">released after the close.</a>
The Russell 2000 index, as replicated by the iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>), climbed 0.8%, while the tech-heavy Nasdaq 100 dipped 0.2%. This marked the ninth time in the last 10 sessions that small caps have outperformed tech stocks. The S&amp;P 500 and the Dow Jones showed little movement.
United Parcel Service Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) stood out among the mega-cap stocks, plunging 14% after missing earnings and revenue estimates for the previous quarter. This decline is poised to be the worst one-day drop for the shipping company since it went public in 1999.
Both Treasury yields and the U.S. dollar remained stable ahead of a data-heavy week, featuring the Q2 GDP report on Thursday and the Fed&#8217;s favored inflation report on Friday.
Gold inched up 0.3%, reaching $2,400 per ounce, while Bitcoin dropped over 2% to $65,800, marking its second straight session of losses.
<h3 class="wp-block-heading">Tuesday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,243.00</td>
<td>0.8%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,568.86</td>
<td>0.1%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>40,386.54</td>
<td>-0.1%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>19,778.53</td>
<td>-0.2%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:48 p.m. ET</figcaption></figure>
According to <a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071924&amp;t=be2bearmibe3na1">Benzinga Pro</a> data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)&nbsp;was flat at $554.92.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;edged down 0.1% to $403.80.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust&nbsp;(ARCA:&nbsp;<a href="https://www.benzinga.com/quote/qqq" target="_blank" rel="noreferrer noopener"></a><a href="https://www.benzinga.com/quote/qqq" target="_blank" rel="noreferrer noopener"></a>QQQ) fell 0.2% to $481.52.</li>
<li>Sector-wise, the Financials Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)&nbsp;outperformed, up by 0.4%, while the&nbsp;Energy Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) lagged, down 1.4%.</li>
</ul>
<h3 class="wp-block-heading">Tuesday&#8217;s Stock Movers</h3>
Stocks reacting to company earnings were: 
<ul>
<li>Agilysys, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGYS#NASDAQ">AGYS</a>), down over 5%</li>
<li>NXP Semiconductors N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) down over 9%</li>
<li>Medpace Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDP#NASDAQ">MEDP</a>) down over 17%</li>
<li>Coca-Cola Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>), up 0.6%</li>
<li>Freeport-McMoRan Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>), down 2%</li>
<li>GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>), up over 7%</li>
<li>General Motors Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>), down over 6%</li>
<li>Kimberly-Clark Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>), down over 4%</li>
<li>Comcast Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>), down over 2%</li>
<li>MSCI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>), up over 7%</li>
<li>Lockheed Martin Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>), up over 4%</li>
<li>Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>), up 2%</li>
<li>PulteGroup, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHM#NYSE">PHM</a>), down 0.5%</li>
<li>Quest Diagnostics Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DGX#NYSE">DGX</a>), down over 4%</li>
<li>Spotify Technology S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>), up over 10%</li>
<li>Polaris Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PII#NYSE">PII</a>), down over 2%.</li>
</ul>
Those reporting after the close include:
<ul>
<li>Alphabet, Capital One Financial Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>)</li>
<li>Chubb Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CB#NYSE">CB</a>)</li>
<li> Mattel, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAT#NASDAQ">MAT</a>)</li>
<li>Packaging Corporation of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PKG#NYSE">PKG</a>)</li>
<li>Seagate Technology Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>)</li>
<li>Tesla</li>
<li>Texas Instruments, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>)</li>
<li>Visa Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>).</li>
</ul>
Read Next:
<ul>
<li><a href="https://bzresearch.myclickfunnels.com/latest-research-webinar-redirect-evergreen?utm_source=website-content" target="_blank" rel="noreferrer noopener">Turn Trading Into The Ultimate Side Hustle Using Benzinga Tools In A Free Webinar</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Equities

Broad U.S. Equity ETFs

Commodities

Small Cap

Econ #s

ETFs

AGYS

CMCSA

SPDR Dow Jones Industrial Average ETF Trust

GOOG

GOOGL

MEDP

NXPI

SPOT

TSLA

Small-Cap Gains Resume Ahead Of Major Tech Earnings; UPS Faces Worst Day Ever, Bitcoin Dips Below $66,000: What's Driving Markets Tuesday?

Shares of Comcast Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>) fell sharply during Tuesday's session after the company reported worse-than-expected <a href="https://www.benzinga.com/news/earnings/24/07/39908857/comcasts-q2-earnings-studios-and-theme-parks-pull-revenue-lower-broadband-and-video-subs-fall">second-quarter sales results</a>.
Comcast reported second-quarter revenue decline of 2.7% year-over-year to $29.69 billion, missing the analyst consensus estimate of $30.02 billion.The company reported adjusted EPS of $1.21, beating analyst consensus estimates of $1.12, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Comcast shares declined 6.1% to $37.12 on Tuesday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Azitra, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZTR#NYSE">AZTR</a>) shares jumped 529% to $10.19 after the company announced that the U.S. Patent and Trademark Office granted it U.S. Patent No. 12,036,248 for the treatment of atopic dermatitis.</li>
<li>Adial Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADIL#NASDAQ">ADIL</a>) jumped 148% to $2.6299 after the company announced it advanced into the second cohort and commenced dosing for the Pharmacokinetics Study of AD04 for alcohol use disorder.</li>
<li>Salarius Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLRX#NASDAQ">SLRX</a>) gained 111% to $3.2540.</li>
<li>Agape ATP Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATPC#NASDAQ">ATPC</a>) shares climbed 67% to $0.2390.</li>
<li>Smart for Life, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMFL#NASDAQ">SMFL</a>) rose 45% to $2.7950.</li>
<li>Dermata Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRMA#NASDAQ">DRMA</a>) gained 43% to $2.41.</li>
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) jumped 36.5% to $4.60.</li>
<li>Volato Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOAR#NYSE">SOAR</a>) gained 33.5% to $0.6385 after jumping around 20% on Monday.</li>
<li>Frequency Electronics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEIM#NASDAQ">FEIM</a>) shares climbed 30% to $13.11 following fourth-quarter earnings. Also, the company declared a $1.00 special cash dividend.</li>
<li>Mammoth Energy Services, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TUSK#NASDAQ">TUSK</a>) gained 26% to $4.42 after the company announced its subsidiary, Cobra Acquisitions, entered into a release and settlement agreement with the Puerto Rico Electric Power Authority.</li>
<li>iClick Interactive Asia Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICLK#NASDAQ">ICLK</a>) rose 23.5% to $2.05.</li>
<li>1847 Holdings LLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFSH#NYSE">EFSH</a>) jumped 19.3% to $2.90.</li>
<li>Milestone Scientific Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLSS#NYSE">MLSS</a>) gained 17.5% to $1.02 after the company announced the Medicare price assignment for its CompuFlo Epidural System.</li>
<li>Staffing 360 Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAF#NASDAQ">STAF</a>) gained 16% to $2.1493.</li>
<li>Kiniksa Pharmaceuticals International, plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KNSA#NASDAQ">KNSA</a>) rose 16% to $24.81 after the company reported better-than-expected second-quarter sales results and raised its FY24 net product revenue guidance.</li>
<li>Aeva Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEVA#NYSE">AEVA</a>) gained 15.1% to $3.6713.</li>
<li>Spotify Technology S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) jumped 12.7% to $333.02 following second-quarter earnings.</li>
<li>NuScale Power Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) gained 11.8% to $12.34.</li>
<li>PureCycle Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>) rose 11.8% to $6.90.</li>
<li>MSCI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) gained 11.1% to $561.96 following better-than-expected second-quarter financial results.</li>
<li>Crown Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCK#NYSE">CCK</a>) rose 8.5% to $84.04 after the company reported better-than-expected second-quarter earnings and raised its FY24 EPS guidance above estimates.</li>
<li>MakeMyTrip Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMYT#NASDAQ">MMYT</a>) gained 8% to $96.75 following better-than-expected quarterly earnings.</li>
<li>Owens &amp; Minor, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMI#NYSE">OMI</a>) gained 8% to $16.51 as the company released preliminary second quarter 2024 financial results and signed a definitive agreement to acquire Rotech Healthcare for $1.36 billion in cash.</li>
<li>Mesoblast Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESO#NASDAQ">MESO</a>) shares surged 8% to $8.15. Mesoblast recently started enrollment in Phase 3 trial of Rexlemestrocel-L for chronic low back pain.</li>
<li>Pentair plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNR#NYSE">PNR</a>) climbed 7.7% to $86.19 after the company reported better-than-expected second quarter financial results and revised its FY24 adjusted EPS guidance above estimates.</li>
<li>Danaher Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) gained 7.4% to $269.35 after the company reported better-than-expected second quarter earnings.</li>
<li>GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>) gained 6.4% to $173.21 after the company reported better-than-expected second quarter adjusted EPS and raised its FY24 outlook.</li>
<li>SAP SE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAP#NYSE">SAP</a>) rose 6% to $0.2390 after the company reported second-quarter financial results.</li>
<li>Zions Bancorporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZION#NASDAQ">ZION</a>) gained 5.4% to $52.12 after posting better-than-expected quarterly results on Monday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Jaguar Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAGX#NASDAQ">JAGX</a>) shares dipped 65% to $1.50 after the company announced its phase 3 OnTarget trial results for Crofelemer did not meet its primary endpoint.</li>
<li>TransCode Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) dipped 62.2% to $0.2999 after the company announced a proposed public offering.</li>
<li>Fly-E Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLYE#NASDAQ">FLYE</a>) tumbled 59.2% to $2.60.</li>
<li>MIRA Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIRA#NASDAQ">MIRA</a>) shares dipped 50.3% to $2.4636. MIRA Pharmaceuticals shares jumped 627% on Monday after the company announced new preclinical study results for its novel oral ketamine analog, Ketamir-2.</li>
<li>CareMax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMAX#NASDAQ">CMAX</a>) shares fell 38.3% to $3.1851 after surging 228% on Monday.</li>
<li>Selina Hospitality PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNA#NASDAQ">SLNA</a>) dipped 32.4% to $0.0250.</li>
<li>PS International Group Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSIG#NASDAQ">PSIG</a>) fell 32.2% to $1.83.</li>
<li>Exicure, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCUR#NASDAQ">XCUR</a>) fell 31.1% to $0.3440.</li>
<li>Cellectar Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLRB#NASDAQ">CLRB</a>) dipped 26.2% to $2.23. The company announced results from its CLOVER WaM pivotal study evaluating iopofosine I 131.</li>
<li>Crown LNG Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGBS#NASDAQ">CGBS</a>) fell 23% to $0.77.</li>
<li>Castellum, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTM#NYSE">CTM</a>) fell 20% to $0.1594. Castellum recently announced a new strategic alliance with Krilla Kaleiwahea.</li>
<li>Netcapital Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCPL#NASDAQ">NCPL</a>) fell 17.3% to $0.0926 after gaining around 8% on Monday.</li>
<li>Medpace Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDP#NASDAQ">MEDP</a>) shares declined 16.6% to $364.00 after the company reported mixed second-quarter financial results and narrowed its FY24 revenue guidance with its midpoint below estimates.</li>
<li>Fitell Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEL#NASDAQ">FTEL</a>) dipped 15.2% to $16.48.</li>
<li>United Parcel Service, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) fell 13.2% to $126.04 after the company reported worse-than-expected quarterly financial results.</li>
<li>Nukkleus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUKK#NASDAQ">NUKK</a>) shares fell 10% to $0.4479 after gaining over 55% on Monday.</li>
<li>NXP Semiconductors N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) shares fell 9.5% to $256.55 following mixed second-quarter earnings.</li>
<li>New Fortress Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFE#NASDAQ">NFE</a>) dipped 9.2% to $23.28.</li>
<li>PACCAR Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCAR#NASDAQ">PCAR</a>) fell 8.4% to $99.92 after the company reported worse-than-expected second-quarter financial results.</li>
<li>A. O. Smith Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>) declined 8.4% to $81.30. The company reported second-quarter financial results.</li>
<li>WEBTOON Entertainment Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBTN#NASDAQ">WBTN</a>) dipped 7.7% to $22.00.</li>
<li>Polaris Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PII#NYSE">PII</a>) declined 7.2% to $76.23 after the company reported worse-than-expected second-quarter financial results and cut its guidance.</li>
<li>Archrock, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AROC#NYSE">AROC</a>) shares declined 6.9% to $21.76. Archrock commenced public offering of 11 million shares of its common stock and announced plans to acquire Total Operations and Production Services for $983 million in cash and stock.</li>
<li>General Motors Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) fell 6.1% to $46.52 after the company reported second-quarter financial results. Also, the company announced that it delayed its 2024 Buick EV and pushed its EV pickup plant opening to 2026.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39907957/microsoft-to-rally-around-10-here-are-10-top-analyst-forecasts-for-monday">Microsoft To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday</a></li>
</ul>

Intraday Update

ADIL

AEVA

AROC

ATPC

AZTR

CGBS

CLRB

CMAX

DRMA

EFSH

FEIM

FLYE

FTEL

ICLK

JAGX

KNSA

MESO

MIRA

MLSS

MMYT

NCPL

NUKK

PCAR

PSIG

RNAZ

SLNA

SLRX

SMFL

SOAR

STAF

TUSK

WBTN

XCUR

ZION

Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

MSCI Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) reported fiscal 2024 second-quarter revenue growth of 14.0% year-on-year to $707.95 million, beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/07/b39901915/msci-reports-financial-results-for-second-quarter-and-six-months-2024" rel="noreferrer noopener">analyst consensus estimate of $696.37 million</a>.&nbsp;
The adjusted EPS of $3.64 beat the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">analyst consensus estimate of $3.55</a>. The stock price gained after the results.
The total&nbsp;run-rate at&nbsp;June 30, 2024, rose 14.6%&nbsp;Y/Y&nbsp;to $2.81 billion.&nbsp;The organic&nbsp;recurring subscription run rate growth was 8.6%. The retention rate was 94.8% compared to 95.5% last year.
The investment research firm&#8217;s index operating revenues rose 9.6% year over year to $397.2 million, aided by higher recurring subscription revenues and asset-based fees.
Analytics operating revenues increased 10.8%&nbsp;Y/Y&nbsp;to $166.0 million, driven by higher recurring subscription revenues from Equity and Multi-Asset Class Analytics products.
ESG and Climate operating revenues grew 12.1%&nbsp;year over year&nbsp;to $79.9 million, driven by solid growth in&nbsp;Ratings, Screening, and Climate products.
All&nbsp;Other&nbsp;–&nbsp;Private Assets&nbsp;operating revenues improved 72.0% Y/Y to $64.9 million.
Margin: The operating margin declined from 55.7% to 54.0%. The adjusted EBITDA margin was stable at 60.7%.
MSCI generated $321.9 million in free cash flow and held $451.4 million in cash and equivalents&nbsp;as of June 30, 2024.
Dividend: The board declared a dividend per share of $1.60 for the third quarter.
&#8220;MSCI&#8217;s second quarter results demonstrate the strength of our all-weather franchise, our blue-chip client base, our wide range of solutions, and our relentless focus on execution,&#8221; said Henry A. Fernandez, Chairman and CEO of MSCI.
FY24 Outlook: MSCI&nbsp;expects operating expense of $1.305 billion &#8211; $1.345 billion (<a target="_blank" href="https://www.benzinga.com/news/earnings/24/04/38383493/whats-going-on-with-msci-stock-on-monday" rel="noreferrer noopener">prior $1.30 billion&nbsp;– $1.34&nbsp;billion</a>), reiterated capex of $95 million&nbsp;– $105&nbsp;million, and free cash flow of $1.225 billion&nbsp;– $1.285&nbsp;billion.
The&nbsp;fiscal revenue and <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">adjusted EPS consensus</a> are $2.83 billion and $14.70.
Price Action:&nbsp;MSCI shares traded higher by 7.46% at $543.77 at the last check on Tuesday.

Guidance

MSCI Q2 Earnings Impress Investors, CEO Emphasizes On Robust Client Base and Execution

BlackRock EuroFund Q2 2024 Commentary

BlackRock International Fund Q2 2024 Commentary

Tracking Ron Baron's BAMCO Portfolio - Q2 2024 Update

Pioneer Global Sustainable Equity Fund Q2 2024 Performance And Market Commentary

TCW Relative Value Large Cap Fund Q2 2024 Commentary

TCW Relative Value Mid Cap Fund Q2 2024 Commentary

Lower interest rates may benefit exchange operators, information analytics companies, Oppenheimer says

MSCI, Moody's, S&P get bull ratings at Evercore, FactSet at In Line, MSCI top pick

Comments

MSCI

뉴스

에 대한 최신 뉴스 MSCI (NYSE:MSCI) 주식

월요일, 4월 29, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌